Central pulse pressure in patients with chronic kidney disease and in renal transplant recipients

Journal of Human Hypertension

Volumn 28, Issue 3, 2014, Pages 180-185

  Ng, K P ^a   Moody, W E ^a   Chue, C D ^a   Edwards, N C ^a   Savage, T ^b   Tomson, C R V ^b   Steeds, R P ^a   Townend, J N ^a   Ferro, C J ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

arterial stiffness; central pulse pressure; chronic kidney disease; left ventricular mass; renal transplant recipients

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; TACROLIMUS;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; AORTA; AORTIC PULSE WAVE VELOCITY; AORTIC WAVE REFLECTION; ARTICLE; AUGMENTATION INDEX; BLOOD PRESSURE MONITOR; BLOOD VESSEL PARAMETERS; BRACHIAL ARTERY; BRACHIAL PULSE PRESSURE; CARDIOVASCULAR MAGNETIC RESONANCE; CENTRAL PULSE PRESSURE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART LEFT VENTRICLE MASS; HEART RATE; HUMAN; HYPERTENSION; IMAGING SOFTWARE; KIDNEY GRAFT; LEFT VENTRICULAR MASS INDEX; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORNING DOSAGE; NUCLEAR MAGNETIC RESONANCE SCANNER; OUTCOME ASSESSMENT; PULSE PRESSURE; PULSE WAVE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; KIDNEY TRANSPLANTATION; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHENOTYPE; PHYSIOLOGY; PROCEDURES;

CARDIOVASCULAR DISEASES; FEMALE; GLOMERULAR FILTRATION RATE; HEART RATE; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; PULSE WAVE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; TRANSPLANT RECIPIENTS;

EID: 84894092653     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2013.71     Document Type: Article

References (35)

1. Moody WE, Edwards NC, Chue CD, Ferro CJ, Townend JN. Arterial disease in chronic kidney disease. Heart 2013;99:365-372.
2. Chue CD, Townend JN, Steeds RP, Ferro CJ. Arterial stiffness in chronic kidney disease: causes and consequences. Heart 2010;96:817-823.
3. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013;3:1-150.
4. Peralta CA, Jacobs Jr. DR, Katz R, Ix JH, Madero M, Duprez DA et al. Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR460 ml/min/1.73m (2): the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2012;59:41-49.
5. Madero M, Peralta C, Katz R, Canada R, Fried L, Najjar S et al. Association of arterial rigidity with incident kidney disease and kidney function decline: the health ABC study. Clin J Am Soc Nephrol 2012;8(3):424-433.
6. van den Hurk K, Magliano DJ, Alssema M, Schlaich MP, Atkins RC, Reutens AT et al. Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study. J Hypertens 2011;29:953-960.
7. Gosse P, Coulon P, Papaioannou G, Litalien J, Lemetayer P. Long-term decline in renal function is linked to initial pulse pressure in the essential hypertensive. J Hypertens 2009;27:1303-1308.
8. Banerjee D, Brincat S, Gregson H, Contreras G, Streather C, Oliveira D et al. Pulse pressure and inhibition of renin-angiotensin system in chronic kidney disease. Nephrol Dial Transplant 2006;21:975-978.
9. Arulkumaran N, Diwakar R, Tahir Z, Mohammed M, Kaski J, Banerjee D. Pulse pressure and progression of chronic kidney disease. J Nephrol 2010;23:189-193.
10. Fernandez-Fresnedo G, Rodrigo E, de Francisco AL, de Castro SS, Castaneda O, Arias M. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients. J Am Soc Nephrol 2006;17:S246-S249.
11. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605.
12. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008;51:1476-1482.
13. Ferro CJ, Steeds RP, Townend JN. Hypertension, arterial haemodynamics and left ventricular disease: historical observations. QJM 2012;105:709-716.
14. Pini R, Cavallini MC, Palmieri V, Marchionni N, Di Bari M, Devereux RB et al. Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study. J Am Coll Cardiol 2008;51:2432-2439.
15. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007;50:197-203.
16. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002;39:735-738.
17. Townsend RR, Chirinos JA, Parsa A, Weir MA, Sozio SM, Lash JP et al. Central pulse pressure in chronic kidney disease: a chronic renal insufficiency cohort ancillary study. Hypertension 2010;56:518-524.
18. Roman MJ, Okin PM, Kizer JR, Lee ET, Howard BV, Devereux RB. Relations of central and brachial blood pressure to left ventricular hypertrophy and geometry: the Strong Heart Study. J Hypertens 2010;28:384-388.
19. Ferro CJ, Savage T, Pinder SJ, Tomson CR. Central aortic pressure augmentation in stable renal transplant recipients. Kidney Int 2002;62:166-171.
20. Wilkinson IB, Fuchs SA, Jansen IM, Spratt JC, Murray GD, Cockcroft JR et al. Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis. J Hypertens 1998;16:2079-2084.
21. Maceira A, Prasad S, Khan M, Pennell D. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2006;8:417-426.
22. Neisius U, Bilo G, Taurino C, McClure JD, Schneider MP, Kawecka-Jaszcz K et al. Association of central and peripheral pulse pressure with intermediate cardiovascular phenotypes. J Hypertens 2012;30:67-74.
23. Benetos A, Thomas F, Joly L, Blacher J, Pannier B, Labat C et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk. J Am Coll Cardiol 2010;55:1032-1037.
24. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010;121:505-511.
25. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and metaanalysis. J Am Coll Cardiol 2010;55:1318-1327.
26. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010;31:1865-1871.
27. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000;35:580-586.
28. Foley RN, Parfrey PS, Harnett JD, Kent GM, Martin CJ, Murray DC et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int 1995;47:186-192.
29. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999;100:1387-1393.
30. Jankowski P, Kawecka-Jaszcz K, Czarnecka D, Brzozowska-Kiszka M, Styczkiewicz K, Loster M et al. Pulsatile but not steady component of blood pressure predicts cardiovascular events in coronary patients. Hypertension 2008;51:848-855.
31. Temmar M, Jankowski P, Peltier M, Mouquet V, Debicka-Dabrowska D, Hamida F et al. Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension 2010;55:327-332.
32. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT). J Am Coll Cardiol 2005;46:1753-1760.
33. Fagard RH, Celis H, Thijs L, Wouters S. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertension 2009;54:1084-1091.
34. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010;55:1314-1322.
35. DeLoach SS, Appel LJ, Chen J, Joffe MM, Gadegbeku CA, Mohler 3rd ER et al. Aortic pulse pressure is associated with carotid IMT in chronic kidney disease: report from Chronic Renal Insufficiency Cohort. Am J Hypertens 2009;22:1235-1241.